High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase

Gaucher disease (GD), the most common lysosomal storage disorder, results from the inherited deficiency of the lysosomal enzyme glucocerebrosidase (GCase). Previously, wildtype GCase was used for high throughput screening (HTS) of large collections of compounds to identify small molecule chaperones...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldin, Ehud, Zheng, Wei, Motabar, Omid, Southall, Noel, Choi, Jae Hyuk, Marugan, Juan, Austin, Christopher P., Sidransky, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260169/
https://www.ncbi.nlm.nih.gov/pubmed/22272254
http://dx.doi.org/10.1371/journal.pone.0029861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260169/
https://www.ncbi.nlm.nih.gov/pubmed/22272254
http://dx.doi.org/10.1371/journal.pone.0029861

Ejemplares similares